Bandingkan Harga & Kinerja Putra Rajawali Kencana Tbk. (PURA) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Putra Rajawali Kencana Tbk. dan Organon Pharma Indonesia Tbk.: Putra Rajawali Kencana Tbk. diperdagangkan di Rp33 (kapitalisasi pasar 214,27 M, volume 24 jam 4,84 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Putra Rajawali Kencana Tbk. jauh lebih besar — sekitar 2,1× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| PURA | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 214,27 M | 104,4 M |
Volume | 4,84 jt | — |
Lot | 48,39 rb | — |
Perputaran | 155,41 jt | — |
Harga Rata-rata | 32,12 | — |
Nilai Transaksi | 155,41 jt | — |
Harga Ekuilibrium Indikatif | 33 | — |
Volume Ekuilibrium Indikatif | 2,7 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Putra Rajawali Kencana Tbk.
PT Putra Rajawali Kencana Tbk (the Company) was established based on notary deed No. 05 dated April 17, 2012 of Juanita Sari Dewi, SH., notary in Surabaya.
Selengkapnya di halaman PURA →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
